The first phase 3 trials are due to start in the first half of next year, using devices manufactured at GSK’s facility in Evreux, France. “If successful, this could lead to regulatory ...

(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer ...

Its Covid vaccine, which is being developed with France's Sanofi, is still undergoing trials. GSK boss Emma Walmsley is selling the company's consumer healthcare division, which makes big-brand ...

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.